The process of development and cellular differentiation is accompanied by heritable modifications to the DNA sequence, principally methylation of CpG dinucleotides. The histone proteins that are bound to DNA are also subject to modifications, including methylation and acetylation. All of these modifications ensure that appropriate genes are selected for expression or repression as part of the generation of diverse cell types. These are epigenetic modifications, as they do not alter the genetic blueprint, which remains essentially unchanged in all cells. They are robust and heritable modifications, and as such ensure that differentiated cells in adults retain their appropriate properties and individual identity throughout adulthood. These modifications have to be erased and re-set during nuclear reprogramming.
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The most dramatic demonstration of nuclear reprogramming is seen following the transfer of a somatic cell nucleus from an adult to an enucleated oocyte ( ., 2005) . Their study reveals that the human fibroblast nucleus is reprogrammed in these hybrid cells. First, the original somatic fibroblast nucleus showed expression of genes associated with pluripotency, while the expression of fibroblast-specific genes was repressed. Second, the ESC-fibroblast hybrid cell exhibited properties akin to those of hESCs, including the capacity for self-renewal over at least 50 passages and the ability to differentiate into a variety of cell types. Finally, OCT4, a key pluripotency-specific gene that is repressed in mature fibroblasts with a methylated promoter region, became unmethylated, a necessary step for reinitiation of its expression. This is a heritable epigenetic modification, which suggests that the effects may not be just transient but could endure subsequently. Overall, the experiments suggest that hESCs probably contain key reprogramming factors that can modify a somatic cell nucleus, returning it to a pluripotent state.
This approach while encouraging requires careful considerations. First, the efficiency of the fusion process between hESCs and somatic cells is very low. This necessitates the use of drugs to select for productive hybrids from among the vast pool of unfused cells. The selection process takes about 10 days, which is a disadvantage as it precludes systematic investigation of the early events leading up to nuclear reprogramming. On the other hand, the prolonged exposure of the somatic nucleus to "reprogramming" factors from the ESC nucleus in hybrid cells may be an advantage. Sec-ond, we cannot say unequivocally that the somatic cell nucleus is reprogrammed as it coexists with the original chromosomes from the ESC in the hybrid cell. To be sure, the ESC chromosomes need to be eliminated from the hybrid cell to see if the somatic cell nucleus continues to display its new identity. Of course, being able to remove the ESC chromosomes while retaining the reprogrammed somatic nucleus would make this procedure extremely valuable even if we do not understand the mechanism. However, this is not possible at present. Nevertheless, the likelihood that hESCs have the potential to reprogram somatic cell nuclei is a big step forward because it means that there is a large volume of biological material available for biochemical characterization of the reprogramming factors present in these cells. There is also the potential to develop cellbased assays to hunt for these key reprogramming factors.
But 
